🇺🇸 FDA
Pipeline program

Iloperidone

VP-VYV-683-2301

Phase 2 small_molecule terminated

Quick answer

Iloperidone for Parkinson Disease Psychosis is a Phase 2 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Vanda Pharmaceuticals
Indication
Parkinson Disease Psychosis
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials